| Literature DB >> 35073901 |
Xue-Min Zhong1, Yao Huang2, Lanying He1, Jian Wang3.
Abstract
BACKGROUND: Prevention and treatment of stroke are extremely important to reduce the incidence of stroke-related disability and the associated death. This study aimed to investigate the current ability of community doctors in stroke management in the Jinjiang district of Chengdu, China, and the effect of intensive education on stroke prevention and management ability of these doctors.Entities:
Keywords: Community doctors; Intensive education; Stroke management; Stroke, stroke prevention and treatment
Mesh:
Year: 2022 PMID: 35073901 PMCID: PMC8788122 DOI: 10.1186/s12909-022-03125-z
Source DB: PubMed Journal: BMC Med Educ ISSN: 1472-6920 Impact factor: 2.463
General information of respondents
| Before intensive education ( | After intensive education ( | ||
|---|---|---|---|
| Sex (%) | 0.622 | ||
| Male | 109 (29.5) | 121 (31.1) | |
| Female | 261 (70.5) | 268 (68.9) | |
| Age (X ± S, y) | 33.0 ± 9.6 | 34.2 ± 10.1 | 0.894 |
| Education level | |||
| Technical secondary school graduates and below | 96 (25.9) | 94 (24.2) | |
| Bachelor | 216 (58.4) | 228 (58.6) | |
| Masters or higher degree | 58 (15.7) | 67 (17.2) | |
| Job title | 0.918 | ||
| Resident | 165 (44.6) | 172 (44.2) | |
| Attending physician | 162 (43.8) | 168 (43.2) | |
| Deputy or chief physician | 43 (11.6) | 49 (12.6) | |
| Specialty before engaging in community health services | 0.436 | ||
| Internal medicine | 228 (61.6) | 241 (62.0) | |
| Surgery | 31 (8.4) | 42 (10.8) | |
| Others | 111 (30.0) | 106 (27.2) | |
| GP education | 181 (48.9) | 204 (52.4) | 0.332 |
| education time (mo) | 3–6 | 3–6 | 1.000 |
| Clinical experience time (y) | 2.5–15.5 | 3–15 | 1.000 |
| Community experience time (y) | 2–10 | 2–10 | 1.000 |
GP general practitioner
Effect of intensive education on the stroke management ability of community doctors
| N (%) | Before intensive education (N = 370) | After intensive education (N = 389) | |
|---|---|---|---|
| Prevention and treatment of cerebrovascular diseases | |||
| Knowledge of relevant guidelines | 140 (37.8) | 265 (68.1) | < 0.001 |
| Classification of stroke | 301 (81.4) | 351 (90.2) | < 0.001 |
| Knowledge of stroke warning signs | < 0.001 | ||
| 0 | 129 (34.9) | 79 (20.3) | |
| 1 | 62 (16.8) | 91 (23.4) | |
| 2 | 49 (13.2) | 42 (10.8) | |
| 3 | 63 (17.0) | 51 (13.1) | |
| 4 | 41 (11.1) | 75 (19.3) | 0.918 |
| 5 | 26 (7.0) | 51 (13.1) | |
| Pre-hospital stroke assessment methods | 9 (2.4) | 109 (28.0) | |
| Management of acute ischemic stroke in community health centers (stations) | < 0.001 | ||
| 0 score | 289 (78.1) | 201 (51.7) | < 0.001 |
| 1 score | 26 (7.0) | 50 (12.9) | |
| 2 score | 21 (5.7) | 41 (10.5) | |
| 3 score | 13 (3.5) | 37 (9.5) | |
| 4 score | 10 (2.7) | 28 (7.2) | |
| Score ≥ 5 | 11 (3.0) | 32 (8.2) | |
| Thrombolytic therapy for acute ischemic stroke | 329 (88.9) | 351 (90.2) | 0.554 |
| Time window for thrombolytic therapy | 149 (45.3) | 214 (61.0) | < 0.001 |
| Risk factors for stroke | < 0.001 | ||
| 0 | 108 (29.2) | 54 (13.9) | |
| 1 | 30 (8.1) | 25 (6.4) | |
| 2 | 44 (11.9) | 28 (7.2) | |
| 3 | 72 (19.5) | 97 (24.9) | |
| 4 | 77 (20.8) | 87 (22.4) | |
| Score ≥ 5 | 39 (10.5) | 98 (25.2) | |
| Definition of TIA | 159 (43.0) | 202 (51.9) | 0.014 |
| TIA management in community health centers | 51 (13.8) | 105 (27.0) | < 0.001 |
| General goal for target BP level for the prevention of recurrent stroke | 247 (66.8) | 289 (74.3) | 0.023 |
| Ideal goal for target BP level for the prevention of recurrent stroke | 170 (45.9) | 215 (55.3) | 0.010 |
| Goal for target HbA1c level for the prevention of recurrent stroke | 152 (41.1) | 239 (61.4) | < 0.001 |
| Goal for BP for the prevention of recurrent stroke in hypertensive patients with diabetes | 152 (41.1) | 239 (61.4) | < 0.001 |
| Awareness of statins therapy for the prevention of recurrent stroke | 199 (53.8) | 301 (77.4) | < 0.001 |
| General goals for LDL-c level for the prevention of recurrent stroke | 28 (7.6) | 107 (27.5) | < 0.001 |
| Side effects of statins | 0.296 | ||
| abnormal liver function | 45 (12.2) | 103 (26.5) | |
| muscle damage | 30 (8.10 | 89 (22.9) | |
| knowing both side effects | 41 (11.1) | 78 (20.1) | |
| Goals for LDL-c level for the prevention of recurrent stroke in patients associated with multiple risk factors or evidence for atherosclerotic vulnerable plaque or arterial embolism | 31 (8.4) | 95 (24.2) | < 0.001 |
| Awareness of warfarin therapy for the prevention of recurrent stroke in patients with atrial fibrillation | 165 (44.6) | 278 (71.5) | < 0.001 |
| Goal for INR level in patients who receive warfarin therapy | 108 (65.5) | 217 (78.1) | 0.004 |
| Awareness of antiplatelet therapy for the prevention of recurrent stroke | 88 (23.8) | 189 (48.6) | < 0.001 |
TIA transient ischemic attack, BP blood pressure, LDL-C low-density lipoprotein cholesterol, INR international normalized ratio